<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>30(30)</volume><submitter>Tandon S</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>F-18 flurpiridaz is a novel radiotracer approved for positron emission tmography (PET) myocardial perfusion imaging. Its long half-life supports exercise stress testing, and its short positron range and high myocardial extraction fraction provide superior image resolution.&lt;h4>Early reports summary&lt;/h4>A 70-year-old man with known coronary artery disease and prior coronary revascularization underwent exercise cardiac PET with F-18 flurpiridaz for chest discomfort. PET showed ischemia in the left anterior descending and right coronary artery territories. Coronary angiography revealed a severe mid-left anterior descending lesion and a severe proximal lesion in a small-caliber right posterior descending artery.&lt;h4>Discussion&lt;/h4>Ischemia on PET correlated with coronary angio</pubmed_abstract><journal>JACC. Case reports</journal><pagination>105279</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12540280</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>First Post-Approval Clinical Use of F-18 Flurpiridaz With Exercise Cardiac PET in the United States.</pubmed_title><pmcid>PMC12540280</pmcid><pubmed_authors>Khalique OK</pubmed_authors><pubmed_authors>Tandon S</pubmed_authors><pubmed_authors>Chen LQ</pubmed_authors></additional><is_claimable>false</is_claimable><name>First Post-Approval Clinical Use of F-18 Flurpiridaz With Exercise Cardiac PET in the United States.</name><description>&lt;h4>Background&lt;/h4>F-18 flurpiridaz is a novel radiotracer approved for positron emission tmography (PET) myocardial perfusion imaging. Its long half-life supports exercise stress testing, and its short positron range and high myocardial extraction fraction provide superior image resolution.&lt;h4>Early reports summary&lt;/h4>A 70-year-old man with known coronary artery disease and prior coronary revascularization underwent exercise cardiac PET with F-18 flurpiridaz for chest discomfort. PET showed ischemia in the left anterior descending and right coronary artery territories. Coronary angiography revealed a severe mid-left anterior descending lesion and a severe proximal lesion in a small-caliber right posterior descending artery.&lt;h4>Discussion&lt;/h4>Ischemia on PET correlated with coronary angio</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-02T03:13:16.136Z</modification><creation>2026-06-02T03:09:04.225Z</creation></dates><accession>S-EPMC12540280</accession><cross_references><pubmed>41043909</pubmed><doi>10.1016/j.jaccas.2025.105279</doi></cross_references></HashMap>